Alberto E. Munoz

Hospital Dr. Carlos Bonorino Udaondo
Buenos Aires, C, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Letter to the Editor: Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC.

Letter to the Editor: Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC.

Journal: Hepatology (Baltimore, Md.)

Published: January 18, 2024

Use of albumin infusion for cirrhosis-related complications: An international position statement.

Use of albumin infusion for cirrhosis-related complications: An international position statement.

Journal: JHEP reports : innovation in hepatology

Published: February 17, 2023

Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients.

Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients.

Journal: Digestive diseases and sciences

Published: September 30, 2022

Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver Cirrhosis.

Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver Cirrhosis.

Journal: Gastroenterologia y hepatologia

Published: January 17, 2022

Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy.

Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy.

Journal: World journal of gastroenterology

Published: December 23, 2020

Assessing the impact of COVID-19 on liver cancer management (CERO-19).

Assessing the impact of COVID-19 on liver cancer management (CERO-19).

Journal: JHEP reports : innovation in hepatology

Published: November 21, 2020

Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.

Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.

Journal: Digestive diseases and sciences

Published: June 11, 2020

Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America.

Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America.

Journal: Journal of medical virology

Published: November 14, 2016

Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.

Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.

Journal: Cytokine

Published: May 16, 2015

Efficacy and safety of long term entecavir in chronic hepatitis B treatment naïve patients in clinical practice.

Efficacy and safety of long term entecavir in chronic hepatitis B treatment naïve patients in clinical practice.

Journal: Annals of hepatology

Published: April 24, 2014

Relapse rates in chronic hepatitis B naïve patients after discontinuation of antiviral therapy with entecavir.

Relapse rates in chronic hepatitis B naïve patients after discontinuation of antiviral therapy with entecavir.

Journal: Journal of viral hepatitis

Published: August 22, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026